title: The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers.
abstract: The accurate harvesting of a sentinel node in gynaecological cancer (i.e. vaginal, vulvar, cervical, endometrial or ovarian cancer) includes a sequence of procedures with components from different medical specialities (nuclear medicine, radiology, surgical oncology and pathology). These guidelines are divided into sectione entitled: Purpose, Background information and definitions, Clinical indications and contraindications for SLN detection, Procedures (in the nuclear medicine department, in the surgical suite, and for radiation dosimetry), and Issues requiring further clarification. The guidelines were prepared for nuclear medicine physicians. The intention is to offer assistance in optimizing the diagnostic information that can currently be obtained from sentinel lymph node procedures. If specific recommendations given cannot be based on evidence from original scientific studies, referral is made to "general consensus" and similar expressions. The recommendations are designed to assist in the practice of referral to, and the performance, interpretation and reporting of all steps of the sentinel node procedure in the hope of setting state-of-the-art standards for high-quality evaluation of possible metastatic spread to the lymphatic system in gynaecological cancer. The final result has been discussed by a group of distinguished experts from the EANM Oncology Committee and the European Society of Gynaecological Oncology (ESGO). The document has been endorsed by the SNMMI Board.
authors.affiliation: Médecine Nucléaire, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon and EMR HCL/UCBL, Faculté de Médecine, Université Claude Bernard, Lyon 1, Villeurbanne, France, francesco.giammarile@chu-lyon.fr.
authors.forename: Francesco
authors.initials: F
authors.lastname: Giammarile
authors.forename: M Fani
authors.initials: MF
authors.lastname: Bozkurt
authors.forename: David
authors.initials: D
authors.lastname: Cibula
authors.forename: Jaume
authors.initials: J
authors.lastname: Pahisa
authors.forename: Wim J
authors.initials: WJ
authors.lastname: Oyen
authors.forename: Pilar
authors.initials: P
authors.lastname: Paredes
authors.forename: Renato Valdes
authors.initials: RV
authors.lastname: Olmos
authors.forename: Sergi Vidal
authors.initials: SV
authors.lastname: Sicart
mesh_terms: D004396:Coloring Agents / Q000378:metabolism; D005260:Female; D005833:Genital Neoplasms, Female / Q000000981:diagnostic imaging* / Q000473:pathology*; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007267:Injections; D061305:Lymphoscintigraphy / Q000379:methods* / Q000592:standards; D009683:Nuclear Medicine / Q000592:standards; D016273:Occupational Exposure / Q000592:standards; D011786:Quality Control; D011850:Radioactive Waste; D011874:Radiometry; D019275:Radiopharmaceuticals; D012107:Research Design; D021701:Sentinel Lymph Node Biopsy / Q000379:methods* / Q000592:standards
chemical_list: D004396:Coloring Agents; D011850:Radioactive Waste; D019275:Radiopharmaceuticals